OPTIPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Optipranolol, and what generic alternatives are available?
Optipranolol is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in OPTIPRANOLOL is metipranolol hydrochloride. There are two drug master file entries for this compound. Additional details are available on the metipranolol hydrochloride profile page.
Summary for OPTIPRANOLOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 4,212 |
DailyMed Link: | OPTIPRANOLOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OPTIPRANOLOL
US Patents and Regulatory Information for OPTIPRANOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | OPTIPRANOLOL | metipranolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019907-001 | Dec 29, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |